Actility Selects iBASIS and Sequans to Deploy LTE-M Solutions With eSIM and iSIM
2.3.2023 18:18:00 EET | Business Wire | Press release
iBASIS, the leading provider of communications solutions for operators and digital players worldwide, and Sequans Communications S.A. (NYSE: SQNS), a leading developer and provider of 5G/4G chips and modules, today announced that Actility, a leading provider of IoT connectivity platform, has chosen iBASIS and Sequans to roll out programmable cellular IoT solutions with eSIM and iSIM.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230227005808/en/
Actility had previously worked closely with iBASIS to enable roaming between private unlicensed networks powered by ThingPark EPC Connector and public networks, using Simfony’s CMP platform, now fully integrated with iBASIS’ Global Access for Things ™ IoT portfolio. The longstanding partnership between iBASIS and Sequans has produced several successful proofs of concept.
The new ultra-low-power multi-technology trackers of Abeeway, a fully owned Actility subsidiary, will benefit from Sequans Monarch 2 LTE-M/NB-IoT platform with integrated iSIM and the connectivity profile provided by iBASIS, allowing the device to connect to cellular networks worldwide. Actility will also benefit from Sequans Monarch 2 being the first iSIM implementation that has achieved common criteria EAL5+ certification, allowing the use of iBASIS’ intelligent profile selection technology with remote update using multiple Tier-1 operator profiles as provided for eSIM.
iSIM is fully integrated in the cellular modem and microcontroller unit on a single system on chip (SoC). It relies on the existing eSIM infrastructure accessing 2/3/4/5G networks using the global footprint of iBASIS. iSIM is considered to be the future of connectivity technology for many IoT deployments.
An important step forward in the IoT industry, iSIM will positively influence device design in the areas of space optimization, and reduction of energy and power consumption. By eliminating the need for a separate SIM chip, iSIM will provide the customer with a more streamlined supply chain experience when manufacturing a device using cellular connectivity. The entire supply chain will benefit from the reduction of materials which will lead to lower costs for manufacturers.
According to Counterpoint Research, beyond 2027 iSIM is projected to take over as the dominant SIM form factor, with the shipments of iSIM-capable devices poised to scale to 7 billion units between 2021 and 2030.
With the iBASIS Global Access for Things™ industry-leading coverage, eSIM/iSIM enables enterprises to easily adopt a single global, remotely programmable SIM that provides mobile data connectivity to smart devices all over the world.
“After recent collaboration with iBASIS, adding iBASIS connectivity on our Monarch 2 module with eSIM, and having fully tested the global connectivity on iSIM, we are now advancing into an integrated production phase driven by a customer need,” said Louis Chuang, EVP of Sequans’ Massive IoT Business Unit. “We are thrilled to reach this important milestone with iBASIS whereby we can offer customers a powerful iSIM capability, along with low power consumption, cost-efficiency, and GNSS support.”
“After being recognized as a leader in the cellular IoT connectivity market with eSIMs, we are delighted to implement iSIM technology together with our trusted partner Sequans,” said Ajay Joseph, CEO IoT & CTO, iBASIS. “After many years of research and development, while deploying iSIM technology in trial environments, it is a great achievement by our teams. This once again underlines that iBASIS is a frontrunner and truly lives by its motto: ‘Be there first’. We strongly believe that iSIM will become a dominant factor within the IoT industry and I am proud to see that we are now able to provide our longstanding customer Actility with our proven IoT connectivity on iSIM.”
“Our focus is ultra-low-power industrial IoT connectivity. The new cellular trackers of our subsidiary Abeeway leverage LTE-M and NB-IoT, and our ThingPark EPC Connector for unlicensed private cellular networks (such as CBRS) rely on recent 3GPP slicing technologies,” said Olivier Hersent, CEO of Actility. “We needed cutting edge partners to support reliable LTE-M connections with PSM/eDRX options in permanent roaming as well as iSIMs: after extensive testing we selected Sequans for their ability to support iSIMs and because 100 percent of their software stack is developed in-house, and iBASIS for their ability to support complex integration and their focus on quality, based on proactive testing. Together, I think we form the dream team for industrial low-power IoT.”
To find out more, visit iBASIS in Hall 2, MR 2A6 and 2A8, and Sequans in Hall 5, Stand 5H40, at Mobile World Congress from February 27 to March 2 in Barcelona.
ABOUT iBASIS
iBASIS is the leading communications solutions provider enabling operators and digital players worldwide to perform and transform. Powered by Tofane Global, iBASIS is the first independent communications specialist, ranking third largest global wholesale voice operator, Top 3 LTE IPX vendor with 700+ LTE destinations, and a leading Carrier Cloud Communications player and IoT solution provider. iBASIS provides the end-to-end Global Access for Things™ connectivity solution, delivering single source cellular IoT access (LTE, LTE-M and NB-IoT) worldwide provisioned through GSMA-standard eSIM/eUICC technology. iBASIS today serves 1,000+ customers across 26 offices worldwide. For more information, please visit iBASIS.com.
ABOUT SEQUANS
Sequans Communications S.A. (NYSE: SQNS) is a leading developer and supplier of cellular IoT connectivity solutions, providing chips and modules for 5G/4G massive and broadband IoT. For 5G/4G massive IoT applications, Sequans provides a comprehensive product portfolio based on its flagship Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms, featuring industry-leading low power consumption, a large set of integrated functionalities, and global deployment capability. For 5G/4G broadband IoT applications, Sequans offers a product portfolio based on its Cassiopeia Cat 4/Cat 6 4G and high-end Taurus 5G chip platforms, optimized for low-cost residential, enterprise, and industrial applications. Founded in 2003, Sequans is based in Paris, France with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Finland, Taiwan, South Korea, and China. Visit Sequans online at www.sequans.com, and follow us on Twitter and LinkedIn.
ABOUT ACTILITY
Actility is the world leader in Low-Power Wide-Area Networks (LPWAN) industrial-grade connectivity solutions for the Internet of Things. Actility provides its ThingPark™ platform and network technology to deploy, operate and maintain public and private wireless IoT networks within a unified, scalable and versatile network infrastructure. The vast majority of nationwide LPWAN network service providers and hundreds of enterprises trust ThingPark™ all over the world. Through its subsidiary Abeeway, Actility also provides patented ultra-low power tracking solutions. ThingPark Market offers the largest selection of interoperable IoT gateways, devices and applications to simplify and accelerate deployment of numerous use cases. Contact us here: https://www.actility.com/contact
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230227005808/en/
Contact information
iBASIS
Céline Gregoire
EVP, Marketing
+1 617.501.2788
cgregoire@iBASIS.net
ACTILITY
Frank Koopman
Executive Vice President EMEAI - Global Head for Geolocation and Enterprise Services
+31 6 51 13 90 39
frank.koopman@actility.com
SEQUANS
Kimberly Tassin
Director, Marketing Communications-
425.736.0569
kimberly@sequans.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns7.7.2026 08:00:00 EEST | Press release
Galderma (SWX:GALD) has unveiled results from the world’s most extensive skin quality profiling survey, finding that skin quality concerns are widespread, can impact emotional wellbeing and, while differing based on the individual, are often similar among people alike in age, lifestyle, and environment.1 These results underscore the need for effective solutions that can be tailored to a wide variety of skin quality concerns. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706426842/en/ Key findings:1 Nine out of ten people globally are affected by skin quality concerns, with each person experiencing an average of two concerns in the past month The most common concerns are fine lines and wrinkles (41%), dry skin (40%), and dull skin (37%), most frequently affecting the face Skin quality impacts quality of life for 85% of people, with more than one in three reporting feelings of self-consciousness, insecurity or anxiety Skin
Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient7.7.2026 05:00:00 EEST | Press release
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy and functional ingredient company, today announced that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status in the United States for LAC-Living+™ (L. helveticus MCC1848), its proprietary postbiotic ingredient. This milestone expands the commercial availability of LAC-Living+ in the U.S. market and enables its use in dietary supplements, functional foods, and beverages, supporting the development of products designed to address growing consumer demand for health and well-being solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706806943/en/ Growing Interest in Postbiotics and Mental Well-Being Consumer interest in proactive health management has expanded significantly in recent years, alongside increasing awareness of the connection between the gut and the brain, commonly referred to as the gut–brain axis. As a result, the g
Access Advance Welcomes New Licensors to the Video Distribution Patent Pool7.7.2026 03:00:00 EEST | Press release
Access Advance LLC today announced that Sharp, M&K Holdings, Tagivan and 9 other patent owners who own substantial video codec patent portfolios that cover the core technologies behind video decoding, processing, and streaming media delivery, have joined the Video Distribution Patent Pool (VDP Pool) in the first half of 2026. "The addition of all of these new Licensors’ patent portfolios is a real win for both the VDP Pool and our many existing and future Licensees,” said Peter Moller, CEO of Access Advance. “These companies have broad and deep patent portfolios and further enhance the program’s market leading position in resolving the licensing issues around the use of modern video codecs across all the diverse business models of internet video streaming.” The following patent holders have joined the VDP Pool as Licensors in the first half of 2026: Digital Insights Inc. Hanbat National University Industry-Academic Cooperation Foundation Hanwha Vision Co., Ltd. Industry-Academy Coopera
Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 02:00:00 EEST | Press release
Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Kath Harrison, Group President, International Growth at Real Chemistry. “By bringing Spurwing into Real Chemistry,
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 23:04:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately $8.8 billion net of estimated cash acquired. The transaction was unanimously approved by both the Vertex and Crinetics Boards of Directors and is anticipated to close in the third quarter of 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706876183/en/ Crinetics’ marketed medicine, PALSONIFY® (paltusotine), received approval from the U.S. Food and Drug Administration (FDA) in September 2025. PALSONIFY was recently approved by the European Medicines Agency (EMA) a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
